XML 78 R64.htm IDEA: XBRL DOCUMENT v3.26.1
Schedule of Components of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 25,920 $ 20,221
Research and development credit carryforwards 928 931
Stock-based and other compensation 2,355 2,135
Lease liability 479 859
Capitalized research and development expenditures 3,520 4,247
Depreciation and amortization 1,315 1,393
Accrued liabilities and other reserves 178 446
Total deferred tax assets 34,695 30,232
Right-of-use and other assets (480) (830)
Total deferred tax liabilities (480) (830)
Valuation allowance (34,215) (29,402)
Net deferred tax asset